Wei X. Chong
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Editorial: Community series in tumor microenvironment and metabolic reprogramming in cancer: volume II.
Journal: Frontiers in immunology
Published: June 02, 2026
Unveiling tumor senescence-driven prognostic heterogeneity via MALISS in stage II/III colorectal cancer.
Journal: Frontiers in immunology
Published: November 12, 2025
The molecular mechanisms of pyroptosis and its implications in tumor immunotherapy.
Journal: Molecular cancer
Published: October 19, 2025
PDIA3 Inhibition Facilitates Sensitivity of IKE-Induced Ferroptosis via STAT3/LCN2 Axis to Improve Glioblastoma Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 28, 2025
The inspiration of methyltransferase in RNA methylation modification for targeted therapy of malignant tumors.
Journal: Frontiers in immunology
Published: July 10, 2025
RBM15 Enhances 5-Fluorouracil Drug Sensitivity and Suppresses Gastric Cancer Progression by Modulating N6-Methyladenosine Modification of ECT2-Dependent IGF2BP3.
Journal: Research (Washington, D.C.)
Published: June 09, 2025
Molybdenum disulfide induces growth inhibition and autophagy-dependent hepatocyte cell death through directly binding and regulating the activity of MST2.
Journal: Materials today. Bio
Published: June 09, 2025
Reinvigorating COTL1high NK cells via GITR signalling overcomes immune checkpoint blockade resistance in tsMHC-I-impaired tumours.
Journal: Nature cell biology
Published: May 17, 2025
18F-FDG PET/CT radiomics for distinguishing LUAD from LUSC in non-small cell lung cancer.
Journal: Medicine
Published: April 08, 2025
Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine-oxaliplatin versus short-course radiotherapy followed by capecitabine-oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial.
Journal: The Lancet. Oncology
Published: February 23, 2025
Molecular characteristics and cancer immunity of LRP1B and its relationship with the Hedgehog signaling pathway in colorectal cancer.
Journal: Frontiers in immunology
Published: January 26, 2025
Last Updated: 09/26/2026